Lpl Financial LLC Galectin Therapeutics Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Lpl Financial LLC holds 81,908 shares of GALT stock, worth $235,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,908

Previous 87,258 6.13%

Holding current value

$235,895

Previous $197,000 14.21%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$2.04 - $2.86 $10,914 - $15,301	-5,350 Reduced 6.13%	81,908 $225,000
Q2 2024 Aug 07, 2024	BUY	$2.13 - $4.2 $68,577 - $135,223	32,196 Added 58.47%	87,258 $197,000
Q1 2024 May 10, 2024	BUY	$1.6 - $2.44 $5,200 - $7,930	3,250 Added 6.27%	55,062 $131,000
Q2 2023 Jul 31, 2023	SELL	$1.32 - $2.08 $660 - $1,040	-500 Reduced 0.96%	51,812 $74,000
Q1 2023 May 10, 2023	SELL	$1.1 - $2.4 $11,287 - $24,626	-10,261 Reduced 16.4%	52,312 $109,000
Q4 2022 Feb 07, 2023	BUY	$1.03 - $1.66 $515 - $830	500 Added 0.81%	62,573 $70,000
Q3 2022 Nov 14, 2022	BUY	$1.31 - $2.48 $4,636 - $8,776	3,539 Added 6.05%	62,073 $101,000
Q1 2022 May 16, 2022	BUY	$1.61 - $2.31 $17,549 - $25,179	10,900 Added 22.88%	58,534 $94,000
Q4 2021 Feb 14, 2022	SELL	$2.07 - $3.8 $3,932 - $7,220	-1,900 Reduced 3.84%	47,634 $99,000
Q3 2021 Nov 15, 2021	SELL	$2.59 - $4.15 $6,475 - $10,375	-2,500 Reduced 4.8%	49,534 $192,000
Q2 2021 Aug 13, 2021	BUY	$2.07 - $5.1 $74,002 - $182,325	35,750 Added 219.54%	52,034 $167,000
Q1 2021 May 14, 2021	SELL	$1.96 - $2.57 $2,548 - $3,341	-1,300 Reduced 7.39%	16,284 $35,000
Q4 2020 Feb 12, 2021	SELL	$2.24 - $2.87 $2,240 - $2,870	-1,000 Reduced 5.38%	17,584 $39,000
Q3 2020 Nov 09, 2020	SELL	$2.53 - $3.64 $24,411 - $35,122	-9,649 Reduced 34.18%	18,584 $50,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.15 $2,858 - $5,424	1,722 Added 6.5%	28,233 $86,000
Q3 2019 Nov 13, 2019	SELL	$3.0 - $4.05 $9,600 - $12,960	-3,200 Reduced 10.77%	26,511 $97,000
Q2 2019 Aug 09, 2019	SELL	$3.61 - $5.0 $7,819 - $10,830	-2,166 Reduced 6.79%	29,711 $123,000
Q1 2019 May 08, 2019	BUY	$3.86 - $6.02 $11,580 - $18,060	3,000 Added 10.39%	31,877 $163,000
Q4 2018 Feb 07, 2019	SELL	$3.43 - $5.74 $3,141 - $5,257	-916 Reduced 3.07%	28,877 $99,000
Q3 2018 Nov 14, 2018	SELL	$3.68 - $6.93 $3,680 - $6,930	-1,000 Reduced 3.25%	29,793 $179,000
Q2 2018 Aug 14, 2018	BUY	$3.16 - $9.16 $22,752 - $65,952	7,200 Added 30.52%	30,793 $196,000
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $89,181 - $140,850	23,593 New	23,593 $112,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.65M

Call Options Held

1.16M

Put Options Held

1.98M

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $171M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Galectin Therapeutics Inc Transaction History